These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12407769)

  • 1. Antisense oligonucleotides targeting RI alpha subunit of protein kinase A. In vitro and in vivo anti-tumor activity and pharmacokinetics.
    Zhang R; Wang H
    Methods Mol Med; 2003; 75():637-54. PubMed ID: 12407769
    [No Abstract]   [Full Text] [Related]  

  • 2. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS; Cho-Chung YS
    Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.
    Neary CL; Cho-Chung YS
    Oncogene; 2001 Nov; 20(55):8019-24. PubMed ID: 11753685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II protein kinase A up-regulation is sufficient to induce growth inhibition in SK-N-SH human neuroblastoma cells.
    Kim SN; Lee GR; Hwang ES; Lee JH; Park SD; Cho-Chung YS; Hong SH
    Biochem Biophys Res Commun; 1997 Mar; 232(2):469-73. PubMed ID: 9125203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotide targeted to RIalpha subunit of cAMP-dependent protein kinase (GEM231) enhances therapeutic effectiveness of cancer chemotherapeutic agent irinotecan in nude mice bearing human cancer xenografts: in vivo synergistic activity, pharmacokinetics and host toxicity.
    Wang H; Hang J; Shi Z; Li M; Yu D; Kandimalla ER; Agrawal S; Zhang R
    Int J Oncol; 2002 Jul; 21(1):73-80. PubMed ID: 12063552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI alpha subunit: p53-independent mechanism of action.
    Srivastava RK; Srivastava AR; Seth P; Agrawal S; Cho-Chung YS
    Mol Cell Biochem; 1999 May; 195(1-2):25-36. PubMed ID: 10395066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration.
    Wang H; Cai Q; Zeng X; Yu D; Agrawal S; Zhang R
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13989-94. PubMed ID: 10570186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancements of antisense oligonucleotides in treatment of breast cancer.
    Yang SP; Song ST; Song HF
    Acta Pharmacol Sin; 2003 Apr; 24(4):289-95. PubMed ID: 12676065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology evaluation: GEM-231, Hybridon Inc.
    Blay J
    Curr Opin Mol Ther; 2000 Aug; 2(4):468-72. PubMed ID: 11249779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
    Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
    J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of novel PKA holoenzymes in human T lymphocytes.
    Orstavik S; Funderud A; Hafte TT; Eikvar S; Jahnsen T; Skålhegg BS
    FEBS J; 2005 Apr; 272(7):1559-67. PubMed ID: 15794744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.
    Mavrakis M; Lippincott-Schwartz J; Stratakis CA; Bossis I
    Hum Mol Genet; 2006 Oct; 15(19):2962-71. PubMed ID: 16963469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment.
    Cho-Chung YS; Nesterova M; Pepe S; Lee GR; Noguchi K; Srivastava RK; Srivastava AR; Alper O; Park YG; Lee YN
    Front Biosci; 1999 Dec; 4():D898-907. PubMed ID: 10577386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between overexpression of the RIalpha subunit of the cAMP-dependent protein kinase and clinicopathological features of lung cancer].
    Shi SS; He ZG; Shao K; Zhou F; Xiong MH; Huang W; Mu BD; Zhang CY; Zhang S; Sun YT; He J
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):547-50. PubMed ID: 15555286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic-AMP and pseudosubstrate effects on type-I A-kinase regulatory and catalytic subunit binding kinetics.
    Anand G; Taylor SS; Johnson DA
    Biochemistry; 2007 Aug; 46(32):9283-91. PubMed ID: 17658893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic binding of PKA regulatory subunit RI alpha.
    Gullingsrud J; Kim C; Taylor SS; McCammon JA
    Structure; 2006 Jan; 14(1):141-9. PubMed ID: 16407073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GTI-2501, an antisense agent targeting R1, the large subunit of human ribonucleotide reductase, shows potent anti-tumor activity against a variety of tumors.
    Lee Y; Vassilakos A; Feng N; Jin H; Wang M; Xiong K; Wright J; Young A
    Int J Oncol; 2006 Feb; 28(2):469-78. PubMed ID: 16391803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.